← feed

Is NCT02998099 results overdue?

Yes — results are overdue. Primary completion was 2017-02; the FDAAA-801 reporting deadline (2018-02-28) passed 3035 days ago and no results are posted on ClinicalTrials.gov.

A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.

NCT IDNCT02998099 ↗
SponsorGlycoMimetics Incorporated (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-02 (ACTUAL)
Reporting deadline2018-02-28 (completion + 365d)
Days overdue3035
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 a77345003792b366… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02998099. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →